BeiGene
BGNE
#881
Rank
NZ$35.84 B
Marketcap
$326.49
Share price
1.71%
Change (1 day)
0.44%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Stock price history for BeiGene (BGNE)

Highest end of day price: $651.62 NZD on 2021-09-17

Lowest end of day price: $38.76 NZD on 2016-02-12

Stock price history of BeiGene from 2016 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$1.61-0.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.39-6.92%๐Ÿ‡บ๐Ÿ‡ธ USA